Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Funding roundtable: ‘You can’t fake it’ and more funding advice from KC founders
Your company is steadily growing, but it looks like you’re nearing a plateau. Perhaps your startup is doing just fine, but a well-heeled competitor just entered your market and slapped a target on your customers. Or maybe you’ve got a solid idea but little dough to get it off the ground. Regardless of the case,…
Techstars firms to spread local roots via Brad Feld’s Kansas City home
More graduates of the Techstars-led Sprint Mobile Accelerator may be calling Kansas City home thanks to venture capitalist Brad Feld. Feld, co-founder of the international accelerator program Techstars, is making his Kansas City, Kan. home available to graduates of the local Techstars program rent free. “I’m very happy with how things have gone to date,”…
Subjective language is making your elevator pitch completely forgettable
Your elevator pitch is the single most important communication of you or your business and why you are relevant. Last month I wrote about how you can use your elevator pitch — or 20-second summary of your business — as a litmus test to determine if you are creating your own market or if you…
Kansas City dishes on diversity in the entrepreneurial community
It’s often said that two heads are better than one. But what if those two “heads” have the same socioeconomic, gender and racial compositions? What if their life experiences mirror one another so closely that they arrive at the same conclusions or generate the same general ideas? It’s no secret that diversity can foster the…